Evidence-based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British Association for Psychopharmacology
TRE Barnes, R Drake, C Paton… - Journal of …, 2020 - journals.sagepub.com
These updated guidelines from the British Association for Psychopharmacology replace the
original version published in 2011. They address the scope and targets of pharmacological …
original version published in 2011. They address the scope and targets of pharmacological …
Is it possible to predict the future in first-episode psychosis?
J Suvisaari, O Mantere, J Keinänen, T Mäntylä… - Frontiers in …, 2018 - frontiersin.org
The outcome of first-episode psychosis (FEP) is highly variable, ranging from early
sustained recovery to antipsychotic treatment resistance from the onset of illness. For …
sustained recovery to antipsychotic treatment resistance from the onset of illness. For …
[图书][B] The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia
American Psychiatric Association - 2020 - books.google.com
The American Psychiatric Association Practice Guideline for the Treatment of Patients With
Schizophrenia seeks to reduce these substantial psychosocial and public health …
Schizophrenia seeks to reduce these substantial psychosocial and public health …
A method for tapering antipsychotic treatment that may minimize the risk of relapse
The process of stopping antipsychotics may be causally related to relapse, potentially linked
to neuroadaptations that persist after cessation, including dopaminergic hypersensitivity …
to neuroadaptations that persist after cessation, including dopaminergic hypersensitivity …
To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic …
MJH Begemann, IA Thompson, W Veling, SS Gangadin… - Trials, 2020 - Springer
Background Antipsychotic medication is effective for symptomatic treatment in schizophrenia-
spectrum disorders. After symptom remission, continuation of antipsychotic treatment is …
spectrum disorders. After symptom remission, continuation of antipsychotic treatment is …
Antipsychotic treatment in the maintenance phase of schizophrenia: an updated systematic review of the guidelines and algorithms
Y Shimomura, Y Kikuchi, T Suzuki, H Uchida… - Schizophrenia …, 2020 - Elsevier
Background We updated our previous systematic review regarding clinical guidelines and
algorithms on antipsychotic treatment in the maintenance phase of schizophrenia (doi …
algorithms on antipsychotic treatment in the maintenance phase of schizophrenia (doi …
Open dialogue for psychosis
N Putman, B Martindale - Organising mental health services to …, 2021 - api.taylorfrancis.com
Names: Putman, Nick, editor.| Martindale, Brian, editor. Title: Open dialogue for psychosis:
organising mental health services to prioritise dialogue, relationship and meaning/edited by …
organising mental health services to prioritise dialogue, relationship and meaning/edited by …
Intervention strategies for ultra-high risk for psychosis: Progress in delaying the onset and reducing the impact of first-episode psychosis
Over a quarter of a century ago, the formulation of the “at risk mental state” and operational
criteria to prospectively identify individuals at “clinical” or “ultra-high risk”(UHR) for psychosis …
criteria to prospectively identify individuals at “clinical” or “ultra-high risk”(UHR) for psychosis …
Self‐reported reasons for discontinuation or continuation of antipsychotic medication in individuals with first‐episode schizophrenia
AE Stürup, C Hjorthøj, HD Jensen… - Early Intervention in …, 2023 - Wiley Online Library
Aim Many individuals with schizophrenia discontinue initially prescribed antipsychotics.
Knowledge on reasons for discontinuation among individuals with first‐episode …
Knowledge on reasons for discontinuation among individuals with first‐episode …
An overview of the currently available and emerging long-acting formulations of risperidone for schizophrenia and bipolar disorder
J Faden, C Ramirez, V Martinez… - Expert Review of …, 2024 - Taylor & Francis
Introduction Long-acting injectable (LAI) antipsychotic medications can help improve
treatment adherence in patients with schizophrenia and bipolar disorder. Despite this, they …
treatment adherence in patients with schizophrenia and bipolar disorder. Despite this, they …